Autologous serum eye drops are made from a patient’s own blood and may help treat severe dry eye and complex ocular surface disorders that do not respond adequately to conventional treatment. Dr Shibal Bhartiya assesses whether this treatment is appropriate based on the underlying condition, severity and response to previous therapies.
Autologous Serum Eye Drops for Severe Dry Eye: When Artificial Tears Are Not Enough,
Why some dry eye patients need biological tears instead of artificial tears, Dr Shibal Bhartiya explains. Most dry eye patients improve with lubricating drops. Some need treatment for meibomian gland dysfunction. Many respond to lifestyle changes and prescription medicines.
But a small group of patients develop severe ocular surface disease. In these cases, routine eye drops are not enough. The surface of the eye is biologically damaged. Healing requires more than lubrication.
This is where autologous serum eye drops can make a major difference.
Serum tears are not routine dry eye treatment. They are used when the eye needs biological support to heal.
Dr Shibal Bhartiya is a fellowship-trained eye specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,700+ patient reviews on Google.
What are autologous serum eye drops?
Autologous serum eye drops are prepared from a patient’s own blood. A small amount of blood is collected. The serum portion is separated. This is diluted in a sterile environment and converted into eye drops.
These drops contain natural healing factors such as:
- Growth factors
- Vitamin A
- Fibronectin
- Epithelial growth factors
- Anti-inflammatory components
- Natural tear proteins
These are substances normally present in healthy tears. Artificial tears cannot replicate this biological complexity.
Serum drops therefore act more like healing therapy than simple lubrication.
Why do some patients need serum tears?
Some diseases damage the corneal surface so severely that lubrication alone cannot restore stability.
These include:
- Severe dry eye disease
- Chronic ocular surface inflammation
- Neurotrophic keratopathy
- Persistent epithelial defects
- Graft versus host disease (GVHD)
- Stevens-Johnson syndrome (SJS)
- Toxic epidermal necrolysis syndrome (TEN)
- Ocular cicatricial pemphigoid
- Post chemical injury eyes
- Post LASIK nerve damage (selected cases)
In these conditions, the problem is not just dryness. The problem is surface failure.
The eye loses its ability to maintain a healthy epithelial layer. Healing becomes slow. Recurrent erosions may occur. Vision fluctuates. Pain may become chronic. Serum drops help restore the biological environment required for healing.
Please read a heartening patient story: Can Eyes Recover From Toxic Epidermal Necrolysis and Stevens-Johnson syndrome?
Serum tears in GVHD related dry eye
Patients who develop ocular graft versus host disease often have some of the most severe dry eye seen in clinical practice.
Inflammation damages:
- Lacrimal glands
- Conjunctiva
- Meibomian glands
- Corneal nerves
These patients often report:
- Severe burning
- Light sensitivity
- Foreign body sensation
- Difficulty keeping eyes open
- Reading fatigue
- Poor tolerance to air conditioning
Many require multiple treatments together. This may include:
- Lubricants
- Topical cyclosporine
- Topical steroids (carefully monitored)
- Punctal occlusion
- Moisture chamber glasses
- Serum tears
Serum drops often form an important part of long-term stabilisation in severe cases.
Serum tears in Stevens Johnson Syndrome (SJS) and TEN
SJS and TEN cause some of the most devastating ocular surface damage.
The disease can lead to:
- Conjunctival scarring
- Lid margin damage
- Loss of goblet cells
- Chronic inflammation
- Severe tear deficiency
- Corneal surface breakdown
Even years after the acute illness, patients may suffer from:
- Chronic dryness
- Pain
- Photophobia
- Recurrent epithelial defects
- Vision fluctuation
These patients often need a multi-layered treatment approach rather than one medication.
Management may include:
- Surface lubrication
- Anti-inflammatory therapy
- Scleral contact lenses
- Mucous membrane grafting (selected cases)
- Serum eye drops
Serum tears are especially useful because they provide biological factors needed for epithelial repair.
How are serum drops different from artificial tears?
Artificial tears mainly provide moisture. Serum drops provide biological healing signals.
Artificial tears lubricate the surface. Serum tears support regeneration.
Artificial tears act as substitutes. Serum tears act as biological therapy.
This distinction is important when deciding which patients benefit most.
When do I consider serum tears for my patients?
I usually consider serum drops when I see:
- Persistent epithelial defects
- Severe punctate keratopathy
- Filamentary keratitis
- Neurotrophic changes
- Poor response to standard therapy
- Chronic ocular surface pain
- Severe symptom–sign mismatch
They are rarely first line therapy. They are part of escalation strategy.
The goal is not just comfort. The goal is surface stabilisation.
How are serum eye drops used?
Serum drops are usually prescribed multiple times daily. Frequency depends on severity.
Patients must store them carefully. Typically:
- Frozen storage for long term supply
- Refrigerated bottle for current use
- Strict hygiene precautions
Because they contain no preservatives, handling instructions are important.
Proper patient education is essential for safety and effectiveness.
Are serum tears safe?
Because the drops are prepared from the patient’s own blood, the risk of allergy is extremely low. However, they must be prepared in laboratories. Sterility protocols must be followed.
Like all advanced therapies, they should be prescribed under specialist supervision.
Monitoring is important. Especially in patients with:
Severe inflammation
Infection risk
Persistent epithelial defects
Complex autoimmune disease
Do serum tears cure severe dry eye?
No treatment cures severe ocular surface disease instantly.
Serum tears are part of long-term stabilisation.
The aim is to:
- Improve comfort
- Promote healing
- Reduce epithelial breakdown
- Improve visual quality
- Reduce surface inflammation
- Prevent complications
In complex disease, success usually comes from combining multiple treatments rather than relying on one therapy.
Why early escalation sometimes matters
One common mistake in severe dry eye is delaying escalation.
Patients may spend years trying multiple lubricants. Sometimes the disease has already progressed beyond simple dryness.
In conditions like GVHD and SJS, early surface protection can prevent long term damage.
This is where specialist evaluation becomes important. Not every dry eye patient needs serum tears. But the right patient may benefit significantly.
The bigger picture in severe ocular surface disease
Severe dry eye is rarely just an eye problem.
It is often part of:
Systemic autoimmune disease
Post transplant immune reactions
Dermatological conditions
Neurological surface dysfunction
Treatment therefore often requires coordination between specialties.
Eye care becomes part of a larger stabilisation strategy.
When should you ask about serum eye drops?
You may benefit from evaluation if you have:
- Severe dry eye not improving with treatment
- Chronic pain despite normal tests
- History of SJS or TEN
- History of bone marrow transplant
- Recurrent corneal erosions
- Extreme light sensitivity
- Difficulty functioning due to dry eye
A detailed ocular surface evaluation helps determine whether serum therapy may help.
The goal is not just comfort. It is stability.
Modern dry eye care is moving toward surface preservation rather than symptom suppression.
The question is no longer just: How dry are the eyes?
It is: Is the surface stable? And is the healing adequate? Is long term damage being prevented?
Serum tears are one of the tools that help answer these questions in complex cases.
This page was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director of Ophthalmology at Marengo Asia Hospitals, Gurugram. For appointments: +91 88826 38735.
Frequently Asked Questions About Serum Eye Drops
What are autologous serum eye drops?
Autologous serum eye drops are made from the liquid component of your own blood. They contain proteins, growth factors and other biological components that may support healing of the eye’s surface. They are prepared under sterile conditions and used for selected ocular surface disorders.
Who may benefit from serum eye drops?
Serum eye drops may be considered for people with severe dry eye that has not responded adequately to conventional treatment, persistent corneal epithelial defects, neurotrophic keratopathy, ocular graft-versus-host disease, or ocular surface damage associated with Stevens-Johnson syndrome. An ophthalmologist must assess whether this treatment is appropriate for your condition.
Are serum eye drops better than artificial tears?
They serve different purposes. Artificial tears lubricate the eye’s surface, while serum eye drops provide biological components that may support epithelial healing. Serum drops are generally reserved for selected patients with severe or treatment-resistant ocular surface disease rather than used as routine first-line treatment.
Are serum eye drops safe?
Serum eye drops can be useful when appropriately prescribed and prepared, but they are not risk-free. Because they usually do not contain preservatives, contamination is an important concern. Sterile preparation, careful handling, correct storage and adherence to your ophthalmologist’s instructions are essential.
How should serum eye drops be stored?
Storage instructions depend on the preparation and dispensing protocol. Some vials need to remain frozen, while the vial currently in use may need refrigeration. Follow the specific instructions provided by your dispensing laboratory and ophthalmologist. Do not use drops that appear cloudy, discoloured or contaminated, or that have been stored incorrectly.
Do serum eye drops cure severe dry eye?
No. Serum eye drops do not guarantee a cure or reverse every form of ocular surface damage. They may improve symptoms and support healing in selected patients. Treatment response varies, and they are usually part of a broader management plan tailored to the underlying condition.
Book a Consultation with Dr Bhartiya
Have severe dry eye symptoms that are not improving with conventional treatment? Autologous serum eye drops may be an option for selected patients with severe ocular surface disease.
Dr Shibal Bhartiya uses a structured, evidence-based approach to dry eye assessment. She reviews previous treatments, identify overlooked contributing factors and determine the next steps in care. The C.L.E.A.R.™ Framework for Dry Eye Second Opinion, devised by Dr Shibal Bhartiya, systematically evaluates each factor to create an individualised treatment plan.
Book an appointment in Gurgaon:
📍 Gurgaon | 📞 +91 88826 38735 | Contact Us | Second Opinion Form for teleconsults to discuss your treatment options.
This article is part of the Dry Eye Hub. Please also read Basics of Dry Eye, Dry Eye Second Opinion and Dry Eye: A Chronic Disease. Why Vision Becomes Blurred After Reading or Screen Use, and Why Are Your Dry Eye Drops Not Working may also help you understand your problem better.
You may also want to read this article written by Dr Bhartiya for NDTV online. And listen to her talk about dry eyes here.
What Do Clinical Practice Guidelines Say About Autologous Serum Eye Drops?
The Indian Journal of Ophthalmology has published preferred practice guidelines for autologous serum eye drops, outlining their role in managing selected cases of severe dry eye and complex ocular surface disease. The guidelines emphasise appropriate patient selection, sterile preparation, safe storage and careful monitoring. Serum eye drops may support ocular surface healing when conventional treatments are insufficient, but their use should be guided by an ophthalmologist experienced in managing these conditions.
Read the guidelines: Preferred Practice Guidelines for the Management of Autologous Serum Eye Drops — Indian Journal of Ophthalmology
The American Academy of Ophthalmology reviewed the evidence for autologous serum eye drops and found that studies reported improvements in symptoms and clinical signs in patients with severe dry eye and persistent corneal epithelial defects. However, the review noted that the evidence was limited by the absence of high-quality controlled trials. PubMed
Read the review: American Academy of Ophthalmology — Autologous Serum-Based Eye Drops
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.
Dr Bhartiya has published peer-reviewed research onglaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes. She is also a committed patient advocate and mainstream medical columnist, translating complex ophthalmic evidence into actionable public health insights across leading national platforms including NDTV and OnlyMyHealth
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery). Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
1700+ Five Star Patient Reviews Google Business Profile
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation
Read her research on PubMed | Google Scholar | ResearchGate | ORCID | Github | Wikidata
📋Upload your reports for a structured review.| 🌐 Contact Us| 📞 +91 88826 38735
⭐ Helped by this article? Leave a Google review — it helps other patients find reliable eye care.
Last Reviewed: October 2026